U.S. Mobilizes Experimental Ebola Therapy and Diagnostics for DRC and Uganda Response
U.S. health agencies are dispatching doses of MBP134, an experimental monoclonal antibody treatment, to the Democratic Republic of the Congo and Uganda for compassionate use and for a randomized trial. The Biomedical Advanced Research and Development Authority has also readied 2,500 rapid diagnostic tests and is soliciting vaccine candidates based …